Liposphere

Company Overview

Snapshot

Founded in February 2019 by Ronit Goldberg and Sabrina Jahn, Liposphere operates with 11–50 employees. The company has secured funding across two rounds, with Daniel Gamsu as an investor, and received a notable grant from the Israel Innovation Authority in June 2019.

Business overview

Liposphere is a biomedical startup focused on developing a platform of highly lubricious, water-based biocompatible nanomaterials. Its core technology can function as a pure lubricant and has future potential for encapsulating active pharmaceutical ingredients for targeted delivery. The company's platform also enables coating artificial medical surfaces, such as contact lenses, catheters, and prostheses, to facilitate smooth movement in various biomedical devices. Liposphere's products, including AqueousJoint for osteoarthritis and an ophthalmic formulation for dry eye syndrome, target the health tech and life sciences sectors, specifically orthopedics and ophthalmology.

Company Intelligence Q&A

What is Liposphere's primary focus?

Liposphere develops a platform of highly lubricous, water-based biocompatible nanomaterials for medical applications requiring ultra-low friction, serving the health tech and life sciences sectors.

When was Liposphere founded?

Liposphere was founded in February 2019.

Who are the founders of Liposphere?

Liposphere was co-founded by Ronit Goldberg and Sabrina Jahn.

What is Liposphere's product strategy?

Liposphere's product strategy includes developing biolubricants like AqueousJoint for osteoarthritis and an ophthalmic formulation for dry eye syndrome, alongside enabling coatings for artificial medical surfaces.

Has Liposphere received any grants?

Yes, Liposphere secured a grant from the Israel Innovation Authority in June 2019.